Arakawa et al. [34] found that there was a significant reduction in serum APN levels in systemic sclerosis patients, which also indicated that serum APN levels may be a useful biomarker for fibrotic condition in systemic sclerosis patients with SSc. The gene discussed is ANPEP; the disease is systemic sclerosis.